Dr. Ivan Augusto Arenas, MD, PhD

Dr. Arenas practices at Salem Hospital in Salem, Oregon, part of Salem Health Hospitals and Clinics.

Dr. Arenas' NPI, 1821227760, was assigned on July 14, 2009. Dr. Arenas holds Oregon license MD205530.

Dr. Arenas' primary practice is Salem Hospital, at 890 Oak Street, SE, Salem, OR 97301 in Marion County. The practice phone is (503) 561-5200.

Dr. Arenas' primary practice is Salem Hospital in Salem, Oregon, part of Salem Health Hospitals and Clinics. Dr. Arenas is also affiliated with Samaritan Albany General Hospital. The medical group on file is Salem Health. Dmand AI also links Dr. Arenas to 2 more hospitals, 2 medical groups and 1 group practice or clinic, each named with a free account. Dr. Arenas' employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Arenas practices, 5 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Arenas' primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dmand AI has Dr. Arenas' licenses on file in 2 states: Oregon and Florida.

CMS data shows 720 Medicare services from Dr. Arenas across 12 procedure codes in 2024, for 521 Medicare patients. Medicare paid $34,225 for them.

CMS counts 521 Medicare patients who saw Dr. Arenas in 2024. The largest group is 65 to 74, with 196 patients. 75% of them have high blood pressure, and 67% have high cholesterol. 24% are also on Medicaid. Their average risk score is 1.56, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Arenas' median patient age at 73, with 55% women.

In 2024, Dr. Arenas wrote 3,103 Medicare Part D claims for 329 patients. 77% of them were for generic drugs. CMS names the drug for 3,002 of them, across 38 drugs with 11 or more claims each, at $515,686 in total drug cost. In 2023, CMS named 1,748 claims across 27 drugs.

Dr. Arenas accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 21 papers to Dr. Arenas, published from 2012 to 2022. 2019 was the busiest year, with 4. The most frequent topics are Chelation Therapy, Chelating Agents and Edetic Acid. Dr. Arenas has published most often in Circ Arrhythm Electrophysiol. Dr. Arenas' most frequent co-authors are Gervasio A. Lamas, MD, Francisco Ujueta, MD and Denisse Diaz, MD.

Dmand AI links Dr. Arenas to 2 clinical trials. 2 are still active or recruiting. Conditions studied include Heart Valve Diseases, Mitral Valve Insufficiency and Tricuspid Valve Insufficiency. Edwards Lifesciences sponsors the most, 2.

CMS Open Payments shows 78 general payments to Dr. Arenas from 16 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 53% of the total. Abbott Laboratories paid the most, $1,496.